InfuSystem slides on a Q2 earnings miss

|About: InfuSystem Holdings, Inc. (INFU)|By:, SA News Editor

InfuSystem (INFU -3.4%) slips after posting a breakeven Q2, missing Street estimates for a penny profit.

Total revenue rose 4% Y/Y, as rental revenues grew by 5% due to a number of catalysts, including: the addition of larger customers, increased existing account penetration, increased use of its products in colorectal cancer and other cancer patients and the continuation of the revision to claims processing guidelines by a major group of third-party payors.

SG&A decreased to $9.5M from $10.2M, down approximately 8% Y/Y.

Gross margin was 71%, compared to 73% in the prior year. The decrease was primarily related to a decrease in rental gross margins from direct pay customers.